Documentation published when available per batch
Combines BPC-157 (cytoprotective) and TB-500 (cell migration/angiogenesis)
The result is improved memory, heightened focus, enhanced learning, and reduced cognitive fatigue
The most common side effects were mild to moderate gastrointestinal issues, with about one-third of patients on the highest orforglipron dose experiencing nausea and about one-quarter experiencing constipation or diarrhea
Arch Med Sci 2021:1 Sampogna G, Di Vincenzo M, Giallonardo V, Perris F, Volpicelli A, Del Vecchio V, Luciano M, Fiorillo A (2022) The psychiatric consequences of long-covid: a scoping review
Efsubaglutide alfa is a long-acting GLP-1 receptor agonist with new human trial data in drug-naive type 2 diabetes